TRDA vs TT · P/E 12, rev $210.8M vs P/E 36, rev $21.32B
Entrada Therapeutics Inc (TRDA) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the TRDA and TT stock pages for the full models.
Not investment advice.